Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN) last traded at $6.81, down 7.09% on the session. The quote above updates while this page is open; the figures below are drawn from Anbio Biotechnology Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Anbio Biotechnology Class A Ordinary Shares trades on NASDAQ under the ticker NNNN. Its market capitalisation is $297.41 million.
Valuation measures for Anbio Biotechnology Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $297.41M |
|---|---|
| Enterprise value | $289.73M |
| P/E ratio | 46.33 |
| Price / sales | 34.39 |
| Price / book | 9.86 |
| Beta | 0.11 |
Trailing-twelve-month figures tagged in Anbio Biotechnology Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $8.65M |
|---|---|
| Net income (TTM) | $6.40M |
| EPS (TTM) | $0.147 |
| Gross margin | 87.24% |
| Operating margin | 66.70% |
| Return on equity | 21.24% |
| Cash | $7.77M |
Range and volume for NNNN over the past 52 weeks.
| 52-week high | $51.33 |
|---|---|
| 52-week low | $6.61 |
| Volume | 78.6K |
| Average volume | 66.1K |
| Previous close | $7.33 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.